The 黑料网 supports collaborating with other medical societies that develop clinical practice guidelines, appropriate use criteria, position statements and other communications related to the practices of diagnostic imaging, medical physics, interventional radiology and radiation oncology. 黑料网 views collaboration as an opportunity to harmonize and improve the delivery of patient care. It is important for the house of medicine to speak with one voice to provide clarity regarding good medical practice for patients and other stakeholders.
It is the College’s preference to be actively engaged in the development or revision of the documents, especially if the goal is to ask for 黑料网 endorsement. When 黑料网 representatives have been engaged in the prior discussions of the scope, recommendations and clinical issues, the endorsement process is facilitated. If review is only available, it is important to understand if changes to the document will be considered and whether the change recommendations have been implemented prior to 黑料网’s endorsement. 黑料网 endorsement on clinical matters is related to diagnostic imaging, medical physics, interventional radiology and radiation oncology. 黑料网’s policy on the endorsement of documents organized by other societies requires a minimum of 30 days for consideration.
Organizations seeking 黑料网’s participation on clinical, practice guidance, or other documents may submit requests by first completing the .
List of Endorsed Collaborative Documents
Newer documents may be in the publication process and will be hyperlinked when they are available from the organizing society; these documents are noted with a *. Older documents whose links are no longer available or have been replaced by a revision are marked with a +. Typically the 黑料网 endorsement is effective for up to five years unless the document has been revised or withdrawn by the sponsoring organization or changes clinical practice make the recommendations or conclusions no longer relevant or valid.
Questions
Please send your questions about 黑料网 collaboration or endorsement to collaborativeguidelines@acr.org.